In fact, there are four holiday meal staples that you might want to skip altogether, according to Dr. Christine Nwoha, who ...

The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, includ ...

Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today ...

The Temple Heart & Vascular Institute is a hub of innovation for treating the whole range of cardiovascular conditions - from ...

USA: The REALIZE-K trial shows that a daily oral potassium binder can safely enable the use of mineralocorticoid receptor ...

On Nov. 18, the heart failure and transplantation team at Emory University Hospital (EUH) made history, performing the first-ever surgical implantation in the United States of a brand-new type of ...

In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, ...

Per an HFSA news release, in the United States, it is estimated that heart failure prevalence may increase to 11.4 million by 2050.

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid ...

The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.

A group of Abbott HeartMates gathered in Buffalo to meet Damar Hamlin and build community around heart health during the ...